To register and for more information here.

The topic of the session is machine learning (ML) and artificial intelligence (AI) and how ML/AI tools are being utilized within the UNITE4TB Consortium to select, test and deliver novel combination TB regimens. Split into two parts, the first 30 minutes of the webinar will be led by Dr. Carlos Talavera-López of Helmholtz Munich (co-lead […]

In commemoration of this year’s World TB Day, UNITE4TB is partnering with ERA4TB to organize a webinar on the topic of community involvement and engagement in early-stage tuberculosis (TB) research. More info here.

People affected with bacterial infections can be involved in every step of antibiotic drug development. Not only can they be receiving an antibiotic treatment that derives from research results, but they can also be contributing partners of research, and even involved in further research. During this Science Communication Interest Group meeting, we explored community engagement […]

The 4th AMR Accelerator Cross-project Meeting for the AMR Accelerator community, a total of 9  projects, took place on 15 Mach 2023 at the Marriott Hotel, Basel, Switzerland. Agenda:   List of registered participants

ERA4TB is launching a series of webinars aimed at exploring key topics in relation to tuberculosis and antimicrobial research and development from clinical, regulatory and HTA perspectives. With the title “Challenges of tuberculosis (TB) drug development and access – clinical, regulatory and HTA perspectives”, the first webinar will be held on 24th November 2022, 11.00-12.15 GMT coinciding with World Antimicrobial […]

We are happy to announce our next TB focused webinar organized by COMBINE named "Tuberculosis, current status update from ongoing research collaborations within the AMR Accelerator". During this webinar you will get the most recent update of ongoing TB research within the IMI AMR Accelerator. The speakers of each TB project will discuss and address […]

Recap of the third UNITE4TB webinar: Progress made to date in shortening TB treatment UNITE4TB held its third public webinar on Thursday 7 July, with a focus on the recent changes in the World Health Organization (WHO) guidelines for the treatment of Tuberculosis (TB) and an evaluation of the evidence underpinning the shortening of TB […]

Antibiotic resistance has created an imminent need for innovative approaches for prevention and therapy of nosocomial infections. Monoclonal antibodies (mAbs) are an increasingly promising strategy, but many hurdles in the development of these products remain. This free online workshop will provide an open discussion forum to identify and prioritize specific challenges and propose mitigation strategies […]

The 3rd AMR Accelerator Cross-project Meeting for the AMR Accelerator community, a total of 9  projects, took place on 06 April 2022 in Basel, Switzerland. Please find more details here and the final agenda below:     DOWNLOAD THE FULL PROGRAMME HERE   DOWNLOAD THE PRESENTATIONS HERE

During this webinar you will get the most recent update of ongoing TB research within the IMI AMR Accelerator. The speakers of each TB project will discuss and address the challenges of their respective TB projects. Further opportunities for leveraging the TB focused initiatives will be discussed.

Recap of the first UNITE4TB webinar: Panel discussion on global burden of TB On 03 March 2022, UNITE4TB held its first in a series of webinars being organized by project partners, Instituto de Saúde Pública da Universidade do Porto (ISPUP) and the European Respiratory Society (ERS). The session featured a presentation by Prof. Mario Raviglione […]

The 2nd Annual meeting for the Cross-IMI AMR Accelerator community was held online on 28 September 2021 and brought together >160 members of the 8 AMR Accelerator projects. After an introduction by COMBINE, a round of project updates was organised with an official introduction of the newest project, UNITE4TB. Martin Boeree, UNITE4TB Project Coordinator, presented […]

The first part of this TB research focused webinar will introduce UNITE4TB, the newest member of the AMR Accelerator. The second part will discuss and address the challenges of the TB research community. We will discuss the fit of the current TB focused portfolio of projects with the global TB community and pipeline. Further activities […]

GNA NOW Open Call webinar II  In case you missed the first webinar on 12 May, this is your second chance to attend the GNA NOW Open Call webinar and ask questions to Project Lead Eric Bacqué of Evotec and Project Coordinator Kristina Orrling of Lygature. The GNA NOW Consortium is looking for a novel […]

  This webinar will cover the use of knowledge management tools in the IMI AMR Accelerator and how these can be used to both enhance data analysis workflows and also promote collaborations across projects and teams. To support these efforts the AMR Data Management group have developed a set of database and visualisation tools based […]

Join us for this online webinar on Wednesday 12 May and find out about a unique opportunity for the antibiotic community. The Innovative Medicines Initiative's GNA NOW Consortium is looking for a novel antibiotic compound to progress to a clinical candidate. To find out more about what the Consortium is looking for, what’s in it […]

The COMBINE project is part of the IMI AMR Accelerator. One of the scientific aims of COMBINE is to improve and standardize the pneumonia animal model used in AMR research and to develop improved tools to reliably translate results in animals into results in humans. Aim of the workshop: This workshop will address the need […]

December 3, 2020, 3.30PM-4.30PM CET Peter Warn is an experienced antimicrobial discovery scientist and consultant with a long and successful record of working in the anti-infective discovery industry. His expertise goes from antimicrobial development (antibacterial, anti-fungal, anti-parasitic and anti Mtb), including in vitro, and animal models from basic models through to PKPD and assisting in […]

This webinar will provide an overview of animal infection models commonly used for studies of antibiotics against gram-negative bacteria. The webinar is driven by the COMBINE objective to harmonize and standardize a protocol for a mouse infection model used for efficacy and PKPD studies. The infection model will be validated through well-characterized bacterial strains and […]

Virtual closed meeting for IMI AMR Accelerator partners to get up to speed with the most novel developments from the Consortium's projects. About this Event IMI AMR Cross-Pillar Meeting (invitation only) This is an online meeting. Dial-in details will be available upon registration. /// WHY YOU SHOULD JOIN /// - Find out about Accelerator projects […]